Course Description

Upon completion of this session, you will learn the proper way to set up for a Regulatory Inspection, ensuring the inspection flows smoothly throughout the duration, and the proper way to speak to inspectors while they are performing the audit.

The purpose of the Regulatory inspection is an activity that should demonstrate that your company is operating according to the proper CFR requirements and maintaining a state of compliance. The key to a successful audit is being able to communicate how your quality systems assure this state of control.


DAY 01(10:00 AM - 3:00 PM EDT)

Module 1: 10:00am – 11:30am


  • Are you ready for FDA Inspection?
  • FDA Investigators – Facts
  • What is the Purpose of an Inspection?
  • What if the Report is negative?
  • What’s the impact
  • Managing the Inspection
  • What to expect in FDA Inspection
  • FDA Inspection Trends
  • Closing meeting

Background/SME management

  • SME Selection
  • SME Training
  • SME “Must – Haves”
  • SME Roadblocks

BREAK 11:30am ET-12:00pm ET

Module 2: 12:00pm ET-1:00pm ET

Preparing for FDA audits

  • What are your issues?
  • Do’s and don'ts of interaction with the inspectors

LUNCH 1:00pm ET-1:30pmET

Module 3: 1:30pm-2:15pm

  • Company preparation
  • FDA Game Show
  • Practice makes perfect
  • Inspection Team – Audit room
  • Pre-planning and preparation activities

Module 4: 2:30-3:00pm


How to do mock inspections

  • Inspection Management Plan
  • Conduct internal audits
  • Benefits of an Internal Audit
  • Audit Process
  • Phases of the Audit
  • How to select an audit team
  • Audit Logistics
  • During the Audit
  • Closing out the Audit

DAY 02(10:00 AM - 3:00 PM EDT)

Module 1: 10:00am – 11:00am

•  Form 483 background

Responses to FDA 483 Observations

  • Things not to say in the response
  • Example of a proper response
  • Warning Letters
  • Responding to a warning letter
  • Request meeting with fda
  • Avoiding enforcement actions 

BREAK 11:00-11:15am

Module 2: 11:15am-12:15pm

Corrective &preventative action (CAPA)and the 483

  • Regulations and CAPA
  • CAPA Defined
  • Elements of an Effective CAPA Process
  • CAPA Simplified
  • Common Principles of RCA
  • General Process for Performing a RCA
  • Establishment of a CAPA Plan
  • CAPA Effectiveness
  • Examples of Effectiveness Check Methods
  • Management expectations
  • Benefits of e-CAPA systems

LUNCH 12:15pm-1:15pm

Module 3: 1:15pm-2:15pm

Real life inspection scenarios

  • Opening Day: Case Study #1 
  • Opening Day: Case Study #2
  • Documentation – Case Study #1
  • Documentation – Case Study #2
  • Documentation – Case Study #3
  • Facility Tours – Case Study
  • SME Situations – Case Study
  • Safety – Case Study
  • Inspection Teams – Case Study

BREAK 2:15-2:30pm

Module 4: 2:30-3:00pm

Case Studies

  • Case Study –Preparing the team
  • Case Study #1 Exercise
  • Case Study #2: Reviewing Support Processes

Conclusion & Q/A

Certificate Awarded

Learning Objectives

Upon completion of this session, attendees will:

  • Learn Pre-planning and preparation activities
  • Know What to do when the investigator arrives
  • Know What documents to have ready and on hand
  • Develop Assignments and responsibilities for the inspection
  • Be Aware of Inspection Do's and Don'ts

Who Will Benefit

  • Quality Control Personnel & Management
  • Manufacturing Personnel & Management
  • Senior Management
  • Regulatory Affairs Personnel & Management
  • Quality Assurance Personnel & Management

Why Should You Attend

You need not dread an FDA inspection if you are adequately prepared. FDA inspections have revealed some trends in recent years. The agency is taking a tougher stand on Quality Systems and using a risk-based approach. Inspectors usually review at least two (2) systems in depth. QA is their number one concern in recent years. They may also look at another system, such as facilities and equipment, materials, production, packaging and labeling or laboratory controls.

FDA does not expect your facility to be perfect. They expect all companies to have some issues. What they really want to see is how you address the problems. The FDA tends to view companies that control these issues to have a high standard of quality. This seminar will help you use the FDA inspection as a learning tool, not as a negative or adversarial experience.

Many times, the arrival of a Regulatory Investigator is a daunting experience for some. This seminar, you will learn how to properly alert key members that an investigator has arrived, the proper protocol for setting up the Inspection room and any associated “war” rooms that will support the inspection, and how to manage requests from the investigators in a timely and accurate manner. This preparation minimizes stress and disorder during the inspections.

Working in a highly regulated industry, we know our firms need to be “inspection-ready” at all times. This is not only to maintain a good rapport with the Regulators, but also as a commitment to quality for our customers, the patients who use our products.

Regulatory inspections should be a time to demonstrate the high level of compliance your firm has to the regulations, and to customer safety and quality. The purpose of a regulatory inspection is to ensure that your facility is in compliance with FDA rules and regulations. Investigators want to know that product was manufactured appropriately and that the current Good Manufacturing Practices are up to FDA standard. An inspection can be very intimidating to all involved, but it is vital if you want an inspection that results in a satisfactory report.

The inspection management plan should provide for, Response to the arrival of the investigators, Guidance of the inspectors’ activities, Procedure for working with the investigators, and Documentation of the inspection. The management plan or SOP should spell out all of the procedures that you will follow during an investigation. Personnel training is one key variable that should be looked at prior to any inspection. Educate personnel about the inspection process so they can be prepared. Train individuals to interface with FDA investigators. Verify that training has been provided for the personnel on their current job functions, and that supporting records are on file. The goal is to minimize the opportunity for incorrect answers provided to the inspectors, or providing too much information. Have a list of what to do and what not to do when speaking to the inspectors as well.

Choose a Purchase Option

FDA Speaker Danielle Delucy

Faculty Danielle DeLucy

Principal/Owner, ASA Training & Quality Consulting, LLC

Gouldsboro, Pennsylvania, United States

Danielle DeLucy, MS, is owner of ASA Training and Consulting, LLC which provides Pharmaceutical and Biologics based companies with training and quality systems assistance in order to meet Regulatory compliance. Prior to this role, Danielle has been in the industry for 15 years serving in numerous Quality Management Roles, such as the Director of Product Quality, the oversight of Sterility Assurance practices and provided QA oversight of numerous filling and packaging operations. Danielle began her QA career as a Quality Control Pharmaceutical Microbiologist at a contract laboratory where she performed various tests for their clients. In the years after, she has held positions in the Quality management arena while increasing her responsibility.

Our Past Seminar Testimonial

The presentation by Carolyn Troiana today was fantastic, both I and the QA Manager (Aaron Neighbour) loved it and had extensive conversation afterward about it. ( FDA Compliance and Mobile Applications Webinar )

Robert Friedland ( IT Manager) NUTEK BRAVO, LLC.

Thank you for providing the information in such detail. It was helpful to gain the perspective of somebody that has implemented these regulations in a working lab. Virtual Seminar on ( Training on Life cycle Management of Analytical Methods and Procedures - according to new FDA and USP guidelines )

Tracey Kessler ( Director of R&D) CEL-SCI Corporation

I felt the seminar was very helpful and provided good insight for DataIntegrity and what the FDA is looking for per the regulations. ( Current Regulatory Thinking on Data Integrity 2 Days Virtual Seminar )

Margaret A. Clifton ( Manager, Quality Systems) CSL Plasma

The presenters subject matter knowledge is extensive which enables information to be shared in detail. (Training Attended on Risk Based Verification and Validation Planning to Meed US FDA and ISO 13485 Requirements )

Stuart Chisholm (Sr. Principal Device Engineer) Teva Pharmaceuticals